De novo postmenopausal endometriosis during tibolone treatment: A case report and review of the literature

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Endometriosis is uncommon before puberty and after menopause as it is an estrogen-dependent disease. A case is presented of postmenopausal endometriosis encountered in a patient who had received tibolone (Livial, Organon, Cambridge, UK) 1 year before the diagnosis of the adnexal mass for 3 months for relief from vasomotor symptoms and had the medication stopped because of fibrocystic disease of the breast. Transvaginal ultrasonography showed homogeneous cystic adnexal mass of 36×26 mm with no internal echoes in the right ovary. Laparoscopic right salpingooophorectomy was performed and the histopathological examination of the cyst showed an endometriotic cyst. Most of the cases with postmenopausal endometriosis are associated with the use of hormone replacement therapy (HRT). However, tibolone is recommended in hormone replacement therapy of postmenopausal symptomatic women who have a past history of hormone-dependent tumors such as endometriosis. There is restricted data in the literature about tibolone use and recurrence or de novo formation of endometriosis. © 2007 Springer-Verlag.

Cite

CITATION STYLE

APA

Dilbaz, B., Tekin, Y. B., Dilbaz, S., & Haberal, A. (2008). De novo postmenopausal endometriosis during tibolone treatment: A case report and review of the literature. Gynecological Surgery, 5(3), 235–237. https://doi.org/10.1007/s10397-007-0355-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free